Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $0.42, $0.18 worse than the analyst estimate of $0.60. Revenue for the quarter came in at $471.2 million versus the consensus estimate of $463.9 million.

For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.